Internal Medicine, Hematology & Oncology · Chicago, IL
NPI
1497708333
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2222 W Division St, Ste 215
Chicago, IL, 60634
Phone (773) 227-8807
Groups this clinician bills Medicare through
Medicare paid, 2024
$547K
28,773 services
Medicare patients, 2024
128
Average age 75
Drug cost, 2024
$2.1M
504 prescriptions
Company payments, 2023
$575
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maciej K Drazkiewicz was code 36415 (venipuncture blood collection), 475 times for 86 patients. In total Maciej K Drazkiewicz billed 28,773 services in 76 codes, and Medicare paid $547K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 475 | 86 | $8.42 | $3,997 |
| 99214 Office E&M - Established | Office | 366 | 88 | $98.24 | $36K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 255 | 20 | $0.51 | $130 |
| 99233 Hospital E&M - Subsequent | Facility | 229 | 33 | $97.39 | $22K |
| 96413 Chemotherapy Administration | Office | 145 | 14 | $99.36 | $14K |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 96 | 11 | $1.01 | $97.13 |
| 96523 Chemotherapy | Office | 54 | 11 | $20.22 | $1,092 |
| 99215 Office E&M - Established | Office | 54 | 23 | $146.61 | $7,917 |
| 99223 Hospital E&M - Initial | Facility | 48 | 31 | $142.08 | $6,820 |
| 99211 Office E&M - Established | Office | 35 | 12 | $18.29 | $640 |
| 96365 Intravenous Infusion, Hydration | Office | 34 | 13 | $48.77 | $1,658 |
| 99204 Office E&M - New | Office | 31 | 31 | $131.60 | $4,079 |
| 99497 Care Management/Coordination | Office | 13 | 13 | $67.64 | $879 |
By year: 2022 $855K for 46,899 services; 2023 $523K for 25,369 services; 2024 $547K for 28,773 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 475 | 86 | $8.42 | $3,997 |
Medicare prescription drug claims, 2024
In 2024, the drug Maciej K Drazkiewicz prescribed most often to Medicare patients was Eliquis (Apixaban), with 60 prescriptions and refills. In total Maciej K Drazkiewicz wrote 504 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 60 | 82 | Under 11 | $46K |
| Valacyclovir Valacyclovir Hcl | 44 | 60 | Under 11 | $1,320 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 43 | 58 | Under 11 | $275 |
| Hydroxyurea Generic | 29 | 61 | Under 11 | $403 |
| Dexamethasone Generic | 27 | 29 | Under 11 | $557 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 26 | 26 | Under 11 | $90K |
| Anastrozole Generic | 24 | 57 | Under 11 | $292 |
| Bicalutamide Generic | 20 | 42 | Under 11 | $413 |
| Darzalex Daratumumab | 20 | 20 | Under 11 | $291K |
| Procrit Epoetin Alfa | 15 | 19 | Under 11 | $80K |
| Tasigna Nilotinib Hcl | 14 | 14 | Under 11 | $332K |
| Bortezomib Generic | 12 | 12 | Under 11 | $1,090 |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $192K |
| Cyclosporine Modified Cyclosporine, Modified | 11 | 13 | Under 11 | $829 |
| Ibrance Palbociclib | 11 | 11 | Under 11 | $173K |
Brand drugs: - claims; generic drugs: 272 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Maciej K Drazkiewicz $575 ($575 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $257.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.